LGB-321

N/A

Report date: 2023/04/20 09:43:39

NME

Base Information

Drug NameLGB-321

Drug Alias NameLGB-321

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionProto-oncogene serine/threonine-protein kinase Pim-1 inhibitorsSerine/threonine-protein kinase pim-3 inhibitorsSerine/threonine-protein kinase pim-2 inhibitors

TargetsProto-oncogene serine/threonine-protein kinase Pim-1Serine/threonine-protein kinase pim-3Serine/threonine-protein kinase pim-2

Therapy Area/IndicationsLeukemia

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesNovartis Pharma Ag

China Registration ClassN/A

Develop Information

Active CompaniesNovartis Pharma Ag

Inactive CompaniesN/A

Active IndicationsLeukemia

Inactive IndicationsN/A

Other Information

ATC CodeN/A